SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Clinical trials for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for head and neck cancer: combo therapy enters phase 3 trial
Disease control Recruiting nowThis phase 3 trial tests two new drug combinations (ivonescimab alone or with ligufalimab) against the standard drug pembrolizumab for people with advanced head and neck cancer that has come back or spread. About 780 adults with PD-L1-positive cancer will take part. The goal is t…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE3 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Half the radiation, same hope: new trial for head and neck cancer
Disease control Recruiting nowThis study compares a shorter, stronger course of radiation (15 sessions) to the standard longer course (30 sessions) after surgery for head and neck cancer. The goal is to see if the shorter schedule works just as well at controlling cancer while reducing treatment time and side…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE2, PHASE3 • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
Glow-in-the-dark dye could help surgeons spot hidden cancer during head and neck surgery
Diagnosis Recruiting nowThis study tests whether a dye called Indocyanine Green (ICG) can help surgeons better see tumor tissue during head and neck cancer surgery. About 30 adults with squamous cell carcinoma who are at risk of recurrence will receive the dye before surgery, and special cameras will ca…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Diagnosis
Last updated May 18, 2026 12:11 UTC
-
Blood test may predict head and neck cancer return
Knowledge-focused Recruiting nowThis study is testing whether a blood test that looks for tumor DNA can find signs of cancer left behind after treatment for head and neck cancer. Researchers will follow 250 adults who have finished curative treatment to see if the test results match up with whether the cancer c…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 26, 2026 07:54 UTC